Neurocrine Biosciences (NBIX) Misses Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $160.74 -1.21%
Revenue Growth %: +26.1%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +26.1%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q4 EPS of ($0.26), $0.02 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- Restoration Hardware (RH) PT Raised to $130 at Stifel After Q1 Earnings
- H.C. Wainwright Reiterates Buy Rating on Anixa Biosciences (ANIX)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
